Skip to content
Inciteful Med

The Diagnostic Workup: Navigating Tests and Biopsies

Last updated:

Diagnosing Sjögren’s involves balancing definitive tests like the lip biopsy against non-invasive options like salivary gland ultrasound (SGUS). While the biopsy is the gold standard for confirmation, it carries a small risk of lip numbness. Other diagnostic tools include the Schirmer’s tear test and saliva flow measurements.

Key Takeaways

  • • The minor salivary gland biopsy is the gold standard for confirming Sjögren's but carries a roughly 4% risk of temporary lip numbness.
  • • Salivary Gland Ultrasound (SGUS) offers a non-invasive, radiation-free alternative to biopsy with high sensitivity.
  • • The 'Early Sjögren’s' panel (SP1, CA6, PSP) is not yet universally accepted as stand-alone proof of disease.
  • • Schirmer’s test and unstimulated whole saliva flow are practical, office-based measures of glandular function.

When blood tests don’t provide a clear answer, the diagnostic workup shifts to more hands-on evaluations. Deciding which tests to undergo requires balancing the need for a definitive diagnosis with the physical reality of the procedures themselves.

The Lip Biopsy: The “Gold Standard”

The Minor Salivary Gland Biopsy (often called a lip biopsy) involves a small incision on the inside of your lower lip to remove 5–10 tiny salivary glands [1][2].

  • Why do it? It is the most reliable way to confirm Sjögren’s if your bloodwork is negative for traditional antibodies. It is also often a requirement for participating in clinical trials [3][4].
  • The Risk of Numbness: The most common concern is paraesthesia (numbness or tingling) in the lip. While roughly 4% of patients experience temporary numbness, permanent loss of feeling is rare, and many cases resolve on their own with conservative management [2][1].
  • Expert Tip: Some surgeons use a specialized clamp (like a chalazion clamp) to minimize bleeding and protect the nerves during the procedure [1].

Salivary Gland Ultrasound (SGUS): The Non-Invasive Alternative

Salivary Gland Ultrasonography (SGUS) is a rapidly growing tool that uses sound waves to look for characteristic “holes” or uneven textures (heterogeneity) in the parotid and submandibular glands [5][6].

  • Benefits: It is painless, non-invasive, and involves no radiation [7].
  • Accuracy: In some studies, SGUS was found to be as sensitive as a biopsy (90%), though it may be slightly less specific [8][9].
  • Current Status: While SGUS is not yet a mandatory part of the official ACR/EULAR classification criteria, many specialists use it to decide if an invasive biopsy is even necessary [7][10].

The “Early Sjögren’s” Panel (SP1, CA6, PSP)

You may be offered a specialized blood panel that tests for “novel” antibodies like SP1, CA6, and PSP [11].

  • The Theory: These antibodies may show up years before traditional ones (like Ro or La) [12][13].
  • The Controversy: While some studies show these markers are prevalent in “early” dry eye patients, they are not yet part of the formal diagnostic criteria used by major rheumatology associations [14][12]. They can be helpful clues, but they are rarely accepted as stand-alone proof of the disease.

Practical Tests: Schirmer’s and Spit

Two of the most common tests are simple but require specific procedures:

  1. Schirmer’s Test: A thin paper strip is tucked into your lower eyelid for 5 minutes to measure tear production [15]. A result of 5mm or less is considered positive for Sjögren’s [16]. Note that the use of numbing drops can change the result by removing “reflex” tearing [17].
  2. Unstimulated Whole Saliva Flow (UWSF): This “spit test” requires you to passively drool into a tube for 5–15 minutes [15]. To get an accurate reading, you must not eat, chew gum, or smoke for a period before the test (usually 60–90 minutes). A flow of 0.1 mL per minute or less is considered a sign of glandular dysfunction [16].

Decision Framework: Should I Get a Biopsy?

Consider a biopsy if:

  • Your blood tests are negative but your symptoms are severe and systemic [18].
  • You need definitive proof for insurance coverage or disability applications.
  • You wish to enroll in a clinical trial for new treatments [4].
  • Other tests (like ultrasound or eye exams) are inconclusive.

Frequently Asked Questions

Is a lip biopsy necessary to diagnose Sjögren's?
A lip biopsy (minor salivary gland biopsy) is considered the gold standard for diagnosis, especially if blood tests are negative. While not always mandatory, it provides definitive proof often required for clinical trial enrollment or disability claims.
What are the risks of a lip biopsy?
The most common risk is temporary numbness or tingling (paraesthesia) in the lip, affecting about 4% of patients. Permanent loss of sensation is rare, and surgeons can use specific techniques to minimize nerve injury.
What is a salivary gland ultrasound (SGUS)?
Salivary Gland Ultrasonography (SGUS) is a painless, non-invasive imaging test that uses sound waves to detect structural changes in the glands. It involves no radiation and, in some cases, can be as sensitive as a biopsy for diagnosis.
What is the "Early Sjögren's" blood panel?
The "Early Sjögren’s" panel tests for antibodies like SP1, CA6, and PSP that may appear before traditional markers. However, these tests are not yet part of the standard diagnostic criteria used by major rheumatology associations.
How is the Schirmer's test performed?
The Schirmer’s test involves placing a thin paper strip in your lower eyelid for five minutes to measure tear production. A result of 5mm or less indicates significantly reduced tear flow, a key sign of the condition.

Questions for Your Doctor

  • • If my Anti-SSA/Ro test is negative, do you recommend a lip biopsy or a salivary gland ultrasound (SGUS) as the next step?
  • • What is your personal experience with the 'Early Sjögren’s' panel (SP1, CA6, PSP), and how would a positive result change my treatment?
  • • For the Schirmer’s test, do you perform it with or without anesthesia? How does that affect the classification score?
  • • If I choose the lip biopsy, what surgical technique do you use to minimize the risk of nerve injury?
  • • Are the results of my spit test (saliva flow) or ultrasound enough to qualify me for specific medications or clinical trials?

Questions for You

  • • Are you primarily seeking a diagnosis for peace of mind, or do you need a definitive 'biopsy-proven' result for disability or a clinical trial?
  • • How do you feel about the roughly 4% risk of temporary lip numbness compared to the clarity a biopsy provides?
  • • Have you had an ultrasound of your cheek glands before? Did the technician mention any 'holes' or 'heterogeneity' in the image?
  • • Are you able to fast and sit still for several minutes to provide a saliva sample (the 'spit test')?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Dry surgical field minor salivary gland harvest using a chalazion clamp for sicca syndrome.

    Wijaya C, Ramli RR, Khoo SG

    The Journal of laryngology and otology 2019; (133(5)):419-423 doi:10.1017/S002221511900077X.

    PMID: 31006413
  2. 2

    Minor Salivary Gland Biopsy in Diagnosis of Sjögren's Syndrome.

    Gordon AJ, Patel A, Zhou F, et al.

    OTO open 2022; (6(3)):2473974X221116107 doi:10.1177/2473974X221116107.

    PMID: 35909442
  3. 3

    Diagnostic Utility of Minor Salivary Gland Biopsy for Primary Sjögren Syndrome in Patients With Negative Anti-SSA Antibodies.

    Goel RR, Jeranko M, Jones L, et al.

    Cureus 2023; (15(9)):e46207 doi:10.7759/cureus.46207.

    PMID: 37905256
  4. 4

    Evaluation of a Practical Approach to Diagnosis of Sjögren Disease in Clinical Practice.

    Shah N, Bookman AAM

    The Journal of rheumatology 2026; (53(1)):38-42 doi:10.3899/jrheum.2025-0574.

    PMID: 40953959
  5. 5

    Salivary gland ultrasonography findings are associated with clinical, histological, and serologic features of Sjögren's syndrome.

    Kim JW, Lee H, Park SH, et al.

    Scandinavian journal of rheumatology 2018; (47(4)):303-310 doi:10.1080/03009742.2017.1374451.

    PMID: 29411664
  6. 6

    The usefulness of ultrasound in the diagnostics of Sjögren's syndrome.

    Saied F, Włodkowska-Korytkowska M, Maślińska M, et al.

    Journal of ultrasonography 2013; (13(53)):202-11 doi:10.15557/JoU.2013.0020.

    PMID: 26675053
  7. 7

    [Sjögren Syndrome : the ENT specialist contributes to the workup].

    Breitenstein A, Brülhart L, Jaquet Y

    Revue medicale suisse 2020; (16(709)):1860-1864.

    PMID: 33026728
  8. 8

    Ultrasonography in the diagnosis of suspected primary Sjögren's syndrome and concordance with salivary gland biopsy: a Spanish single-center study.

    Barrio-Nogal L, Novella-Navarro M, Heras CB, et al.

    Clinical rheumatology 2023; (42(9)):2409-2417 doi:10.1007/s10067-023-06618-4.

    PMID: 37225928
  9. 9

    Diagnostic accuracy of ultrasonography in relation to salivary gland biopsy in Sjögren's syndrome: a systematic review with meta-analysis.

    Martins FB, Oliveira MB, Oliveira LM, et al.

    Dento maxillo facial radiology 2024; (53(2)):91-102 doi:10.1093/dmfr/twad007.

    PMID: 38177085
  10. 10

    Normal salivary gland ultrasonography could rule out the diagnosis of Sjögren's syndrome in anti-SSA-negative patients with sicca syndrome.

    Al Tabaa O, Gouze H, Hamroun S, et al.

    RMD open 2021; (7(1)) doi:10.1136/rmdopen-2020-001503.

    PMID: 33510043
  11. 11

    Evaluation of Autoantibodies in Patients with Primary and Secondary Sjogren's Syndrome.

    De Langhe E, Bossuyt X, Shen L, et al.

    The open rheumatology journal 2017; (11()):10-15 doi:10.2174/1874312901711010010.

    PMID: 28400867
  12. 12

    Analysis of novel Sjogren's syndrome autoantibodies in patients with dry eyes.

    Everett S, Vishwanath S, Cavero V, et al.

    BMC ophthalmology 2017; (17(1)):20 doi:10.1186/s12886-017-0412-8.

    PMID: 28270126
  13. 13

    Clinical Correlations of Novel Autoantibodies in Patients with Dry Eye.

    Karakus S, Baer AN, Akpek EK

    Journal of immunology research 2019; (2019()):7935451 doi:10.1155/2019/7935451.

    PMID: 30766890
  14. 14

    Utility of Novel Autoantibodies in the Diagnosis of Sjögren's Syndrome Among Patients With Dry Eye.

    Karakus S, Baer AN, Agrawal D, et al.

    Cornea 2018; (37(4)):405-411 doi:10.1097/ICO.0000000000001471.

    PMID: 29504954
  15. 15

    2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome: A consensus and data-driven methodology involving three international patient cohorts.

    Shiboski CH, Shiboski SC, Seror R, et al.

    Annals of the rheumatic diseases 2017; (76(1)):9-16 doi:10.1136/annrheumdis-2016-210571.

    PMID: 27789466
  16. 16

    2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts.

    Shiboski CH, Shiboski SC, Seror R, et al.

    Arthritis & rheumatology (Hoboken, N.J.) 2017; (69(1)):35-45 doi:10.1002/art.39859.

    PMID: 27785888
  17. 17

    Human Lacrimal Production Rates from Modified Schirmer-Tear Test.

    Li S, Kim YH, Li W, et al.

    Optometry and vision science : official publication of the American Academy of Optometry 2018; (95(4)):343-348 doi:10.1097/OPX.0000000000001196.

    PMID: 29561502
  18. 18

    Minor salivary gland biopsy in clinically suspected Sjögren's disease: still indispensable for seronegative cases?

    Kaban N, Bakay U

    Zeitschrift fur Rheumatologie 2025; (84(Suppl 5)):193-201 doi:10.1007/s00393-025-01746-5.

    PMID: 41168553

This guide explains diagnostic procedures for Sjögren's syndrome for educational purposes. Always consult your rheumatologist to determine which tests are appropriate for your specific situation.

Stay up to date

Get notified when new research about Sjögren's Syndrome is published.

No spam. Unsubscribe anytime.